Our findings identify the opposite after ATZ treatment: the animals decreased all parameters related to HFD-induced obesity, although catalase activity was not completely inhibited in WAT, which supported our second line of reasoning for the mechanism of action for ATZ: heme synthesis inhibition which, in turn, blocks adipogenesis. The gene discussed is CAT; the disease is obesity disorder.